pilocarpine has been researched along with trypsinogen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dagorn, JC; Giorgi, D; Iovanna, J; Renaud, W | 1 |
| Blythe, SA; Farrell, PM | 1 |
| Farrell, PM; Koscik, RE | 1 |
| Farrell, PM; Hoffman, G; Kopish, GJ; Laessig, RH; Litsheim, TJ; Rock, MJ | 1 |
1 review(s) available for pilocarpine and trypsinogen
| Article | Year |
|---|---|
Advances in the diagnosis and management of cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chlorides; Cystic Fibrosis; Humans; Infant; Infant, Newborn; Mass Screening; Pancreatitis; Pilocarpine; Respiratory Tract Infections; Sweat; Trypsinogen | 1984 |
3 other study(ies) available for pilocarpine and trypsinogen
| Article | Year |
|---|---|
Regulation of concentrations of mRNA for amylase, trypsinogen I and chymotrypsinogen B in rat pancreas by secretagogues.
Topics: Amylases; Animals; Ceruletide; Cholecystokinin; Chymotrypsinogen; Gene Expression Regulation; Male; Pancreas; Pilocarpine; Rats; Rats, Inbred Strains; RNA, Messenger; Trypsinogen | 1986 |
Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
Topics: Age Factors; Alleles; Base Composition; Chlorides; Codon; Cystic Fibrosis; DNA; Follow-Up Studies; Gene Deletion; Genes, Regulator; Genotype; Heterozygote; Homozygote; Humans; Infant; Infant, Newborn; Iontophoresis; Mutation; Neonatal Screening; Parasympathomimetics; Pilocarpine; Sweat; Trypsinogen | 1996 |
Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Topics: Age Factors; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Early Diagnosis; Electrophoresis, Polyacrylamide Gel; Fluoroimmunoassay; Heterozygote; Homozygote; Humans; Incidence; Infant; Infant, Newborn; Iontophoresis; Muscarinic Agonists; Neonatal Screening; Pilocarpine; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Sweat; Trypsinogen; Wisconsin | 2005 |